Telescope announces debt settlement transaction
October 23, 2025 — The Company has entered into agreements to settle certain outstanding indebtedness through the issuance of 689,654 common shares (each, a “Share”) of the Company (the “Debt Settlement”).
Telescope issues Stock Options and Shares for debt
October 15, 2025 — The Company has granted 1,544,000 incentive stock options (the “Options”) to certain directors, employees and consultants.
Telescope closes final tranche of private placement
October 14, 2025 — Gross proceeds of $1,296,704 were raised in this final tranche.
Telescope closes initial tranche of private placement
September 15, 2025 — Gross proceeds of $5,203,296 were raised in this initial tranche.
Telescope Innovations appoints Vaso Vlachos as Chief Operating Officer
September 2, 2025 — Ms. Vlachos brings
over 20 years of experience managing automation and analytical technology offerings for the biopharmaceutical and chemical industries.
Telescope Innovations, Corporation to Present at the Virtual Life Science Investor Forum March 13th
March 11, 2025 — Telescope Innovations invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Telescope Innovations Advances Self-Driving Lab Deployment, Strengthening Industry Impact
February 24, 2025 — Telescope’s Self-Driving Lab (“SDL”) technology integrates AI, robotics, advanced analytics, and chemistry to accelerate research and development.
Telescope Innovations Becomes Certified Systems Integrator of Universal Robots
October 15, 2024 — Certification enables faster development and deployment of Telescope’s Self-Driving Labs.
